(+)-catechin multiple interactions ISO RGD:1318297 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of MOCOS mRNA CTD PMID:24763279 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1318297 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MOCOS mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions ISO RGD:1616767 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MOCOS mRNA CTD PMID:36331819 1,2-dimethylhydrazine decreases expression ISO RGD:1616767 6480464 1, 2-Dimethylhydrazine results in decreased expression of MOCOS mRNA CTD PMID:22206623 1-nitropyrene increases expression ISO RGD:1318297 6480464 1-nitropyrene results in increased expression of MOCOS mRNA CTD PMID:19041380 17alpha-ethynylestradiol increases expression ISO RGD:1616767 6480464 Ethinyl Estradiol results in increased expression of MOCOS mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1318297 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of MOCOS mRNA CTD PMID:30165855 17beta-estradiol increases expression ISO RGD:1318297 6480464 Estradiol results in increased expression of MOCOS mRNA CTD PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1616767 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of MOCOS mRNA CTD PMID:16214954 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1318297 6480464 Tetrachlorodibenzodioxin results in increased expression of MOCOS mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1616767 6480464 Tetrachlorodibenzodioxin affects the expression of MOCOS mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MOCOS mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1616767 6480464 Tetrachlorodibenzodioxin results in increased expression of MOCOS mRNA CTD PMID:18796159 , PMID:28922406 3,7-dihydropurine-6-thione multiple interactions ISO RGD:1318297 6480464 [MOCOS gene SNP results in decreased oxidation of Mercaptopurine] which results in decreased chemical synthesis of 6-thiouric acid more ... CTD PMID:29935280 3,7-dihydropurine-6-thione decreases oxidation ISO RGD:1318297 6480464 MOCOS gene SNP results in decreased oxidation of Mercaptopurine CTD PMID:29935280 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of MOCOS protein CTD PMID:34915118 4-hydroxynon-2-enal increases expression ISO RGD:1616767 6480464 4-hydroxy-2-nonenal results in increased expression of MOCOS mRNA CTD PMID:19191707 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of MOCOS mRNA CTD PMID:24780913 6-Thiourate multiple interactions ISO RGD:1318297 6480464 [MOCOS gene SNP results in decreased oxidation of Mercaptopurine] which results in decreased chemical synthesis of 6-thiouric acid CTD PMID:29935280 8-Br-cAMP increases expression ISO RGD:1318297 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MOCOS mRNA CTD PMID:22079614 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of MOCOS mRNA CTD PMID:30779732 arsenite(3-) multiple interactions ISO RGD:1318297 6480464 arsenite inhibits the reaction [G3BP1 protein binds to MOCOS mRNA] CTD PMID:32406909 arsenous acid increases expression ISO RGD:1318297 6480464 Arsenic Trioxide results in increased expression of MOCOS mRNA CTD PMID:20458559 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of MOCOS gene CTD PMID:28931070 azathioprine multiple interactions ISO RGD:1318297 6480464 MOCOS gene SNP results in decreased metabolism of and affects the susceptibility to Azathioprine CTD PMID:29935280 benzo[a]pyrene increases expression ISO RGD:1616767 6480464 Benzo(a)pyrene results in increased expression of MOCOS mRNA CTD PMID:19770486 more ... benzo[a]pyrene increases methylation ISO RGD:1318297 6480464 Benzo(a)pyrene results in increased methylation of MOCOS promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1318297 6480464 Benzo(a)pyrene results in increased expression of MOCOS mRNA CTD PMID:22316170 , PMID:26238291 Benzo[k]fluoranthene decreases expression ISO RGD:1616767 6480464 benzo(k)fluoranthene results in decreased expression of MOCOS mRNA CTD PMID:26377693 bisphenol A decreases expression ISO RGD:1616767 6480464 bisphenol A results in decreased expression of MOCOS mRNA CTD PMID:23798566 bisphenol A decreases expression ISO RGD:1318297 6480464 bisphenol A results in decreased expression of MOCOS protein CTD PMID:33376534 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MOCOS mRNA CTD PMID:32145629 , PMID:34947998 bisphenol A increases expression ISO RGD:1616767 6480464 bisphenol A results in increased expression of MOCOS mRNA CTD PMID:34585602 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MOCOS mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A increases expression ISO RGD:1318297 6480464 bisphenol A results in increased expression of MOCOS mRNA CTD PMID:29275510 bisphenol A affects expression ISO RGD:1318297 6480464 bisphenol A affects the expression of MOCOS mRNA CTD PMID:30903817 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MOCOS mRNA CTD PMID:25181051 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of MOCOS mRNA CTD PMID:32479839 butan-1-ol multiple interactions ISO RGD:1318297 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MOCOS mRNA CTD PMID:29432896 cadmium sulfate increases expression ISO RGD:1616767 6480464 cadmium sulfate results in increased expression of MOCOS mRNA CTD PMID:16221973 caffeine increases phosphorylation ISO RGD:1318297 6480464 Caffeine results in increased phosphorylation of MOCOS protein CTD PMID:35688186 carbamazepine affects expression ISO RGD:1318297 6480464 Carbamazepine affects the expression of MOCOS mRNA CTD PMID:25979313 chromium(6+) affects expression ISO RGD:1318297 6480464 chromium hexavalent ion affects the expression of MOCOS mRNA CTD PMID:30690063 cisplatin increases expression ISO RGD:1318297 6480464 Cisplatin results in increased expression of MOCOS mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1318297 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of MOCOS mRNA CTD PMID:27392435 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of MOCOS mRNA CTD PMID:24386269 copper atom multiple interactions ISO RGD:1318297 6480464 [NSC 689534 binds to Copper] which results in increased expression of MOCOS mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1318297 6480464 [NSC 689534 binds to Copper] which results in increased expression of MOCOS mRNA CTD PMID:20971185 copper(II) sulfate increases expression ISO RGD:1318297 6480464 Copper Sulfate results in increased expression of MOCOS mRNA CTD PMID:19549813 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of MOCOS mRNA CTD PMID:27523638 cyclosporin A increases expression ISO RGD:1318297 6480464 Cyclosporine results in increased expression of MOCOS mRNA CTD PMID:20106945 more ... diarsenic trioxide increases expression ISO RGD:1318297 6480464 Arsenic Trioxide results in increased expression of MOCOS mRNA CTD PMID:20458559 Didecyldimethylammonium increases expression ISO RGD:1318297 6480464 didecyldimethylammonium results in increased expression of MOCOS mRNA CTD PMID:32763356 disodium selenite decreases expression ISO RGD:1318297 6480464 Sodium Selenite results in decreased expression of MOCOS mRNA CTD PMID:18175754 dorsomorphin multiple interactions ISO RGD:1318297 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of MOCOS mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1318297 6480464 entinostat results in increased expression of MOCOS mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1318297 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MOCOS mRNA CTD PMID:27188386 epoxiconazole increases expression ISO RGD:1616767 6480464 epoxiconazole results in increased expression of MOCOS mRNA CTD PMID:35436446 etoposide affects response to substance ISO RGD:1318297 6480464 MOCOS protein affects the susceptibility to Etoposide CTD PMID:16217747 genistein decreases expression ISO RGD:1616767 6480464 Genistein results in decreased expression of MOCOS mRNA CTD PMID:32186404 inulin multiple interactions ISO RGD:1616767 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MOCOS mRNA CTD PMID:36331819 isotretinoin decreases expression ISO RGD:1318297 6480464 Isotretinoin results in decreased expression of MOCOS mRNA CTD PMID:20436886 lead diacetate increases expression ISO RGD:1616767 6480464 lead acetate results in increased expression of MOCOS mRNA CTD PMID:22609695 lucanthone decreases expression ISO RGD:1318297 6480464 Lucanthone results in decreased expression of MOCOS mRNA CTD PMID:21148553 mercaptopurine decreases oxidation ISO RGD:1318297 6480464 MOCOS gene SNP results in decreased oxidation of Mercaptopurine CTD PMID:29935280 mercaptopurine multiple interactions ISO RGD:1318297 6480464 [MOCOS gene SNP results in decreased oxidation of Mercaptopurine] which results in decreased chemical synthesis of 6-thiouric acid more ... CTD PMID:29935280 metformin decreases expression EXP 6480464 Metformin results in decreased expression of MOCOS mRNA CTD PMID:31324951 mitoxantrone affects response to substance ISO RGD:1318297 6480464 MOCOS protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:1616767 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of MOCOS mRNA CTD PMID:20061341 , PMID:25566086 N-methyl-4-phenylpyridinium increases expression ISO RGD:1318297 6480464 1-Methyl-4-phenylpyridinium results in increased expression of MOCOS mRNA CTD PMID:24810058 paracetamol affects expression ISO RGD:1616767 6480464 Acetaminophen affects the expression of MOCOS mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MOCOS mRNA CTD PMID:33387578 pentachlorophenol increases expression ISO RGD:1616767 6480464 Pentachlorophenol results in increased expression of MOCOS mRNA CTD PMID:23892564 perfluorohexanesulfonic acid increases expression ISO RGD:1318297 6480464 perfluorohexanesulfonic acid results in increased expression of MOCOS mRNA CTD PMID:25812627 perfluorononanoic acid increases expression ISO RGD:1318297 6480464 perfluoro-n-nonanoic acid results in increased expression of MOCOS mRNA CTD PMID:25812627 , PMID:32588087 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1616767 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MOCOS mRNA, [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MOCOS mRNA CTD PMID:36331819 phenylmercury acetate multiple interactions ISO RGD:1318297 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MOCOS mRNA CTD PMID:27188386 potassium chromate decreases expression ISO RGD:1318297 6480464 potassium chromate(VI) results in decreased expression of MOCOS mRNA CTD PMID:22079256 potassium chromate increases expression ISO RGD:1318297 6480464 potassium chromate(VI) results in increased expression of MOCOS mRNA CTD PMID:22714537 potassium chromate multiple interactions ISO RGD:1318297 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MOCOS mRNA CTD PMID:22079256 purine-6-thiol multiple interactions ISO RGD:1318297 6480464 [MOCOS gene SNP results in decreased oxidation of Mercaptopurine] which results in decreased chemical synthesis of 6-thiouric acid more ... CTD PMID:29935280 purine-6-thiol decreases oxidation ISO RGD:1318297 6480464 MOCOS gene SNP results in decreased oxidation of Mercaptopurine CTD PMID:29935280 quercetin decreases expression ISO RGD:1318297 6480464 Quercetin results in decreased expression of MOCOS mRNA CTD PMID:21632981 SB 431542 multiple interactions ISO RGD:1318297 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1318297 6480464 Silicon Dioxide results in decreased expression of MOCOS mRNA CTD PMID:25351596 silicon dioxide increases expression ISO RGD:1616767 6480464 Silicon Dioxide results in increased expression of MOCOS mRNA CTD PMID:29203145 silver atom increases expression ISO RGD:1616767 6480464 Silver results in increased expression of MOCOS mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:1616767 6480464 Silver results in increased expression of MOCOS mRNA CTD PMID:27131904 succimer multiple interactions ISO RGD:1616767 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MOCOS mRNA CTD PMID:21641980 sunitinib increases expression ISO RGD:1318297 6480464 Sunitinib results in increased expression of MOCOS mRNA CTD PMID:31533062 temozolomide increases expression ISO RGD:1318297 6480464 Temozolomide results in increased expression of MOCOS mRNA CTD PMID:31758290 tioguanine multiple interactions ISO RGD:1318297 6480464 [MOCOS gene SNP results in decreased oxidation of Mercaptopurine] which results in increased chemical synthesis of Thioguanine CTD PMID:29935280 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of MOCOS mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1318297 6480464 trichostatin A results in increased expression of MOCOS mRNA CTD PMID:24935251 triclosan increases expression ISO RGD:1318297 6480464 Triclosan results in increased expression of MOCOS mRNA CTD PMID:30510588 valproic acid increases expression ISO RGD:1318297 6480464 Valproic Acid results in increased expression of MOCOS mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1318297 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MOCOS mRNA CTD PMID:27188386 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of MOCOS mRNA CTD PMID:23034163